Literature DB >> 11591366

Pim-1 translocates sorting nexin 6/TRAF4-associated factor 2 from cytoplasm to nucleus.

Y Ishibashi1, H Maita, M Yano, N Koike, K Tamai, H Ariga, S M Iguchi-Ariga.   

Abstract

Pim-1, an oncogene product of serine/threonine kinase, has been found to play roles in apoptosis induction/suppression, cell-cycle progression and transcriptional regulation by phosphorylating the target proteins involved in these processes. The target proteins phosphorylated by Pim-1, including p100, Cdc25A, PAP-1 and heterochromatin protein 1, have been identified. The precise functions of Pim-1, however, are still poorly understood. In this study, we identified tumor necrosis factor receptor-associated factor 4-associated factor 2/sorting nexin 6 (TFAF2/SNX6) as a Pim-1-binding protein, and we found that TFAF2/SNX6 was phosphorylated and translocated from the cytoplasm to nucleus by Pim-1. This translocation of the protein was not affected by Pim-1-dependent phosphorylation. Since sorting nexins, including TFAF2/SNX6, have been reported to be located in the cytoplasm or membrane by association with several receptors of tyrosine- or serine/threonine-kinase, this is the first report of TFAF2/SNX6 being located in the nucleus after binding to Pim-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591366     DOI: 10.1016/s0014-5793(01)02881-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

Review 1.  Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis.

Authors:  Beata Pyrzynska; Iwona Pilecka; Marta Miaczynska
Journal:  Mol Oncol       Date:  2009-06-11       Impact factor: 6.603

Review 2.  The role of Pim kinase in immunomodulation.

Authors:  Zhaoyun Liu; Mei Han; Kai Ding; Rong Fu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 3.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

4.  Abstrakt interacts with and regulates the expression of sorting nexin-2.

Authors:  Mohammad Abdul-Ghani; Kristin L Hartman; Johnny K Ngsee
Journal:  J Cell Physiol       Date:  2005-07       Impact factor: 6.384

Review 5.  A systematic review on active sites and functions of PIM-1 protein.

Authors:  Youyi Zhao; Aziz Ur Rehman Aziz; Hangyu Zhang; Zhengyao Zhang; Na Li; Bo Liu
Journal:  Hum Cell       Date:  2022-01-09       Impact factor: 4.174

Review 6.  BAR the door: cancer suppression by amphiphysin-like genes.

Authors:  George C Prendergast; Alexander J Muller; Arivudanambi Ramalingam; Mee Young Chang
Journal:  Biochim Biophys Acta       Date:  2008-09-18

7.  Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation.

Authors:  Jian Chen; Masanobu Kobayashi; Stephanie Darmanin; Yi Qiao; Christopher Gully; Ruiying Zhao; Satoshi Kondo; Hua Wang; Huamin Wang; Sai-Ching Jim Yeung; Mong-Hong Lee
Journal:  Am J Pathol       Date:  2009-06-15       Impact factor: 4.307

8.  PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.

Authors:  L Brault; T Menter; E C Obermann; S Knapp; S Thommen; J Schwaller; A Tzankov
Journal:  Br J Cancer       Date:  2012-06-21       Impact factor: 7.640

9.  Association of Nuclear PIM1 Expression with Lymph Node Metastasis and Poor Prognosis in Patients with Lung Adenocarcinoma and Squamous Cell Carcinoma.

Authors:  Richeng Jiang; Xinyue Wang; Ziliang Jin; Kai Li
Journal:  J Cancer       Date:  2016-01-10       Impact factor: 4.207

10.  Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia.

Authors:  Maja Narlik-Grassow; Carmen Blanco-Aparicio; Yolanda Cecilia; Marco Perez; Sandra Muñoz-Galvan; Marta Cañamero; Oliver Renner; Amancio Carnero
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.